Remineralization of lytic spinal metastases after radiotherapy

Publication date

2023-04

Authors

Pielkenrood, Bart J
Visser, Thomas F.
van Tol, Floris R
Foppen, WouterORCID 0000-0003-4970-8555
Eppinga, Wietse S.C.ISNI 0000000389239685
Verhoeff, JoostORCID 0000-0001-9673-0793ISNI 0000000393929005
Bol, G HORCID 0000-0002-7393-167XISNI 0000000392489626
van der Velden, Joanne M.
Verlaan, Jorrit-JanORCID 0000-0001-8105-6660ISNI 0000000392776086

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

BACKGROUND CONTEXT: Palliative radiotherapy (RT) can lead to remineralization of osteolytic lesions thereby potentially restoring some of the weight-bearing capacity and preventing vertebral collapse. It is not clear, however, under which circumstances remineralization of osteolytic lesions occurs. PURPOSE: The aim of this study was to investigate the change in bone mineral density in spinal metastases after RT compared to a reference region, and find associated factors. STUDY DESIGN: Retrospective analysis within prospective observational cohort OUTCOME MEASURES: change in bone mineral density measured in Hounsfield Units (HU). PATIENT SAMPLE: patients treated with RT for (painful) bone metastases. METHODS: Patients with spinal metastases were included if computed tomography scans both pre- and post-RT were available. Bone density was measured in HU. A region of interest (ROI) was drawn manually in the metastatic lesion. As a reference, a measurement of bone density in adjacent, unaffected, and non-irradiated vertebrae was used. Factors tested for association were origin of the primary tumor, RT dose and fractionation scheme, and concomitant use of bisphosphonates. RESULTS: A total of 31 patients with 49 spinal metastases, originating from various primary tumors, were included. The median age on baseline was 58 years (IQR: 53–63) and median time between baseline and follow-up scan was 8.2 months (IQR: 3.0–18.4). Difference in HU in the lesion before and after treatment was 146.9 HU (95% CI 68.4–225.4; p<.01). Difference in HU in the reference vertebra between baseline and first follow-up was 19.1 HU (95% CI -47.9 to 86.0; p=.58). Difference between reference vertebrae and metastatic lesions on baseline was -194.1 HU (95% CI -276.2 to -112.0; p<.01). After RT, this difference was reduced to -50.3 HU (95% CI -199.6 to 99.0; p=.52). Patients using bisphosphonates showed a greater increase in HU, 194.1 HU versus 60.6 HU, p=.01. CONCLUSIONS: Palliative radiation of osteolytic lytic spinal metastases is positively associated with an increased bone mineral density at follow-up. The use of bisphosphonates was linked to an increased bone mineral density when used during or after RT.

Keywords

Bone Density, Bone metastases, Hounsfield Units, Orthopedic surgery, Radiotherapy, Remineralization, Spinal metastases, Vertebral Fractures, Clinical Neurology, Surgery, Orthopedics and Sports Medicine, Journal Article

Citation

Pielkenrood, B J, Visser, T F, van Tol, F R, Foppen, W, Eppinga, W S C, Verhoeff, J J C, Bol, G H, Van der Velden, J M & Verlaan, J J 2023, 'Remineralization of lytic spinal metastases after radiotherapy', The Spine Journal, vol. 23, no. 4, pp. 571-578. https://doi.org/10.1016/j.spinee.2022.12.018